Execution Version CONSENt LETTER TO THE CREDIt AGREEMENt CONSENt LETTER TO THE CREDIt AGREEMENt, dated as of September 13, 2024 (this 「Agreement」), by and among the Borrower (as defined below), each other Guarantor (as defined in the Credit Agreement (as defined below)) as of the date hereof, Holdings (as defined below), Blue Owl Capital Corporation, in its capacity as the administrative agent (in such capacity, the 「Administrative Agent」), and each of the Lenders signatory hereto constituting the Consenting Term Lenders (as defined in Amendment No. 11 (as defined below)) under the Credit Agreement (as defined below). WHEREAS, reference is hereby made to the Credit Agreement, dated as of September 13, 2019 (as amended by Amendment No. 1 to the Credit Agreement and Incremental Facility Amendment, dated as of March 20, 2020, Incremental Facility Agreement and Technical Amendment No. 2 to Credit Agreement, dated as of May 7, 2020, Incremental Facility Agreement No. 3, dated as of June 11, 2020, Amendment No. 4 to the Credit Agreement and Incremental Facility Agreement, dated as of May 7, 2021, Amendment No. 5 to Credit Agreement and Incremental Facility Agreement, dated as of June 11, 2021, Amendment No. 6 to the Credit Agreement and Incremental Facility Agreement, dated as of November 10, 2021, Amendment No. 7 to Credit Agreement, dated as of March 14, 2022, Amendment No. 8 to the Credit Agreement, dated as of August 12, 2022, Amendment No. 9 to the Credit Agreement, dated as of November 9, 2022, Amendment No. 10 to the Credit Agreement, dated as of March 15, 2023, Amendment No. 11 to the Credit Agreement, dated as of March 12, 2024 (「Amendment No. 11」), Consent Letter to the Credit Agreement, dated as of August 28, 2024 (the 「Consent Letter」), and as further amended, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof and as in existence immediately prior to the date hereof, the 「Credit Agreement」), among Blizzard Midco, LLC, a Delaware limited liability company (「Holdings」), Norvax, LLC, a Delaware limited liability company (the 「Borrower」), the Lenders from time to time party thereto, the Administrative Agent and the other parties party thereto; WHEREAS, the Borrower has requested that each Consenting Term Lender (as defined in Amendment No. 11) agree to extend the due date of the Amendment No. 11 Deferred Consent Fee (as defined in Amendment No. 11 after giving effect to the Consent Letter) pursuant to Section 9(b) of Amendment No. 11 (after giving effect to the Consent Letter) from September 13, 2024 to September 23, 2024 (the 「Deferred Fee Extension」); WHEREAS, in accordance with Section 9.02 of the Credit Agreement, Holdings, the Borrower, the Guarantors, the Administrative Agent and each Lender party hereto constituting a Consenting Term Lender have agreed to the Deferred Fee Extension, on the terms set forth herein; NOW, THEREFORE, the parties hereto agree as follows: Section 1. Defined Terms; References. Unless otherwise specifically defined herein, each term used herein which is defined in the Credit Agreement has the meaning assigned to such term in the Credit Agreement. Section 2. Consent. Each Lender that is a Consenting Term Lender and that delivers its signature page to this Agreement hereby consents to the Deferred Fee Extension such that, after giving effect thereto, Section 9(b) of Amendment No. 11 shall read as follow: (b) on September 23, 2024, a non-refundable consent fee, which fee shall be fully earned on the Amendment No. 11 Effective Date (the 「Amendment No. 11 Deferred Consent Fee」) and payable in cash in an amount equal to 1.00% multiplied by the sum of the aggregate